J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio

Episode 4 (January 12, 2024): Takeaways from the J.P. Morgan Health Care conference: Illumina, Danaher, 10x, Empress Therapeutics; an interview with Liberate Bio’s Shawn Davis and Walter Strapps. Listed below are references to relevant GEN stories discussed in this episode of Touching Base: JPM: Illumina’s new CEO spells out 2024 priorities, presents preliminary Q4 2023 results By Alex Philippidis, GEN, January 10, 2024. JPM: Prime Medicine eyes 2024 IND for first prime editing therapy By Alex Philippidis, GEN, January 9, 2024 JPM 2024: Veracyte’s C2i genomics acquisition adds AI readouts to liquid biopsy testing By Jonathan D. Grinstein, GEN, January 8, 2024 JPM: More M&A “firepower” in store for 2024, EY predicts By Alex Philippidis, GEN, January 8, 2024  Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jan 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio

0:00 43:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Touching Base?

This episode is 43 minutes long.

When was this Touching Base episode published?

This episode was published on January 11, 2024.

Can I download this Touching Base episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!